Non-survivors in our study had higher levels of inflammatory markers (WBC, procalcitonin, CRP, and IL-6) as well as lower anemia related parameters (RBC, hemoglobin, and hematocrit), which concurs with current publications [30]. The gene discussed is CRP; the disease is anemia.